Overview
Age related macular degeneration is the most common reason
for vision loss in people aged above 50. It results in depreciation of the
macula that may lead to distorted or blurry central vision. The predisposing
factors involved are age, smoking, sunlight, heredity etc. Symptoms include
development of blind spot and hazy vision. The condition may be treated by
photodynamic therapy, radiation therapy and medication such as anti-angiogenic
drugs.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/1555347-age-related-macular-degeneration-pipeline-review-h1-2017
Report
Highlights
The Pharmaceutical and Healthcare latest pipeline guide Age
Related Macular Degeneration - Pipeline Review, H1 2017, provides comprehensive
information on the therapeutics under development for Age Related Macular
Degeneration (Ophthalmology), complete with analysis by stage of development,
drug target, mechanism of action (MoA), route of administration (RoA) and
molecule type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and
press releases.
The Age Related Macular Degeneration (Ophthalmology) pipeline
guide also reviews of key players involved in therapeutic development for Age
Related Macular Degeneration and features dormant and discontinued projects.
The guide covers therapeutics under Development by Companies /Universities
/Institutes, the molecules developed by Companies in Phase III, Phase II, Phase
I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 8, 31, 19, 4,
121, 30 and 1 respectively. Similarly, the Universities portfolio in Phase II,
Phase I, Preclinical and Discovery stages comprises 1, 1, 15 and 3 molecules,
respectively.
Age Related Macular Degeneration (Ophthalmology) pipeline
guide helps in identifying and tracking emerging players in the market and
their portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage. Additionally,
various dynamic tracking processes ensure that the most recent developments are
captured on a real time basis.
Major Scope of the report:
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Age Related Macular Degeneration (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Age Related Macular Degeneration (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Age Related Macular Degeneration (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide reviews pipeline therapeutics for Age Related Macular Degeneration (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Age Related Macular Degeneration (Ophthalmology) therapeutics and enlists all their major and minor projects.
Table of Contents
- Procure strategically important competitor information,
analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Age Related Macular Degeneration (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Age Related Macular Degeneration (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1555347-age-related-macular-degeneration-pipeline-review-h1-2017
About Us
Wise Guy
Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium
progressive statistical surveying, market research reports, analysis &
forecast data for industries and governments around the globe. Wise Guy Reports
understand how essential statistical surveying information is for your
organization or association. Therefore, we have associated with the top
publishers and research firms all specialized in specific domains, ensuring you
will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner
Relations & Marketing Manager
Ph:
+1-646-845-9349 (US)
Ph: +44 208
133 9349 (UK)
No comments:
Post a Comment